12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

• Axcella Health (NASDAQ:AXLA) stock rose 14.4% to $0.52 during Tuesday's after-market session. Axcella Health's trading volume hit 61.8 million shares by close, accounting for 4940.4% of its average volume over the last 100 days. The company's market cap stands at $37.9 million.
• Carmell Therapeutics (NASDAQ:CTCX) stock moved upwards by 8.69% to $4.0. The market value of their outstanding shares is at $92.3 million.
• ContraFect (NASDAQ:CFRX) stock moved upwards by 8.08% to $0.79. The market value of their outstanding shares is at $8.4 million.
• Infinity Pharmaceuticals (NASDAQ:INFI) shares rose 7.81% to $0.09. Infinity Pharmaceuticals's trading volume hit 290.2K shares by close, accounting for 8.9% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
• Beyond Air (NASDAQ:XAIR) stock rose 7.42% to $3.04. The company's market cap stands at $96.4 million.
• Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 6.61% to $4.48. The company's market cap stands at $19.1 million.

Losers

• FibroGen (NASDAQ:FGEN) shares declined by 18.0% to $1.05 during Tuesday's after-market session. Trading volume for this security closed at 690.6K, accounting for 20.8% of its average full-day volume over the last 100 days. The company's market cap stands at $103.1 million.
• TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 12.8% to $1.5. The market value of their outstanding shares is at $3.0 million.
• Precipio (NASDAQ:PRPO) stock fell 7.69% to $0.34. The market value of their outstanding shares is at $9.2 million.
• AEON Biopharma (AMEX:AEON) stock fell 7.47% to $3.72. The company's market cap stands at $138.2 million.
• Vaccinex (NASDAQ:VCNX) shares decreased by 6.83% to $0.21. The market value of their outstanding shares is at $14.6 million.
• NanoVibronix (NASDAQ:NAOV) shares declined by 6.81% to $1.37. The market value of their outstanding shares is at $2.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.